By using sensitive radioimmunoassays to identify hepatitis A and hepatitis B virus infections another variant of acute hepatitis has been discovered in which no immunological markers of hepatitis A or B can be detected (Feinstone et al., 1975) . The agent(s) responsible for this type of hepatitis, called 'non-A, non-B', have not yet been identified, and the diagnosis is essentially one of exclusion. The disease may be defined as a type of acute hepatitis, clinically and histologically indistinguishable from hepatitis A and B but lacking serological markers for the two latter types.
Progression of acute hepatitis B to chronic liver disease is well documented whereas no such progression has been documented for hepatitis A infection. We describe two patients in whom acute hepatitis type non-A, non-B progressed to chronic liver disease. and found to be negative. Also analyses for antibodies to the hepatitis B core antigen (anti-HBc) by immunoelectro-osmophoresis (Hansson and Johnsson, 1971) and hepatitis Be antigen (HBeAg) and its antibody by immunodiffusion (Magnius et al., 1975) were found to be negative. Analyses for antibodies against hepatitis A virus (anti-HAV) by radioimmunoassay (Frosner et al., 1977) (Fig. 6 ) and two years (Figs 2 and 3) , respectively, after the initial attack of jaundice, a significant portal and periportal reaction with accumulation of mononuclear cells and a slight fibrosis with tendency to septal proliferation was observed in both cases. The hepatocytes in case 1 showed diffuse damage with slight hydropic degeneration (Figs 2  and 3 ). In case 2 (Fig. 6) , more pronounced hepatocellular damage with fairly marked hydropic degeneration and some ballooning was seen. In both cases there was erosion of the limiting plates and loss of individual cells in the periportal parenchyma (piecemeal necrosis).
Thus at the onset of symptoms a histological picture consistent with acute viral hepatitis and, in addition, slight steatosis was seen. At follow-up one and two years later chronic inflammatory changes resembling chronic active hepatitis had developed. In the second case progressive hepatocellular damage was apparent, and the patient died from liver insufficiency within three years of the onset of symptoms.
Discussion
Hepatitis type non-A, non-B may, like hepatitis B infection, progress to chronic liver disease in certain cases. Hoofnagle and his associates (1977) observed development of chronic hepatitis in two of six subjects experimentally infected with hepatitis type non-A, non-B. In a study on post-transfusion hepatitis, Knodell et al. (1977) found 10 cases of chronic liver disease among 44 patients with non-A, non-B hepatitis.
The two patients in the present report are examples of a histologically confirmed progression from acute hepatitis, serologically classified as type non-A, non-B, to chronic active hepatitis. They also had clinical and immunological abnormalities consistent with a progression to chronic liver disease.
It may be argued that the histological changes seen at the onset of illness, even if hepatitis-like, may have been caused by exogenous factors such as drugs or alcohol, especially since both patients had a slight steatosis. However, both patients denied the use of known hepatotoxic drugs. In both cases, a moderate weekly intake of alcohol may explain the slight steatosis found.
The true incidence of chronic liver disease after hepatitis type non-A, non-B is not known. The incidence found by Hoofnagle et al. (1977) and Knodell et al. (1977) was 33 % and 25 %, respectively.
However, it seems unlikely that as many as onethird to one-fourth of non-A, non-B hepatitis cases progress to chronic liver disease, since among 56 cases of acute non-A, non-B hepatitis followed up in Gothenburg, Sweden (Norkrans et al., 1979) only four patients (7 %) had abnormal liver function tests for more than one year. In that material only seven patients (14%) had received transfusions of blood or blood products, and it is possible that non-A, non-B hepatitis not associated with blood transfusions bears a better prognosis.
The two cases presented here were found when 44 patients with chronic active hepatitis (CAH) were investigated for the presence of hepatitis A and B markers in serum (Lindberg et al., 1978) . Nine of these patients showed histological progression from acute viral hepatitis to CAH. Three of the patients had hepatitis B markers in serum, four had hepatitis A markers, while two patients (those of the present report) were lacking both A-and B-markers in the serum; no increased frequency of anti-HAV antibodies was found in CAH patients compared to age-matched healthy controls, and an aetiological relationship between hepatitis A virus and CAH therefore seems unlikely. Hence, the presence of anti-HAV in patients with acute viral hepatitis developing CAH does not exclude the fact that the disease may in fact be induced by a non-A, non-B infection. Thus, in two to six of the 44 patients (5-14%), CAH may be regarded as possibly having been induced by hepatitis non-A, non-B.
Hepatitis virus non-A, non-B, although still not demonstrable, must be taken into account in the search for aetiological factors in chronic hepatitis and cryptogenic cirrhosis. The true incidence of cases attributable to this agent, however, remains to be determined. 
